Cartesian Therapeutics, Inc. — Director's Dealing 2016

Dec 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-12-21

Reporting Person: Abraham David (CCO, Gen.Counsel, Corp.Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-21	Common Stock	M	12280	$0.47	Acquired	14844	Direct
2016-12-21	Common Stock	S	14844	$18.00	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-21	Employee Stock Option (right to buy)	$0.47	M	12280	Disposed	2019-07-23	Common Stock (12280)	Direct

Footnotes

F1: These securities are fully vested.